Edward V. Loftus

66.7k citations

773 papers · 37.2k indexed · 16 hit papers · h-index 98

Impact in

Genetics top 0.01%
- Inflammatory Bowel Disease
Epidemiology top 0.01%
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders

Papers in

Genetics 604
- Inflammatory Bowel Disease 602
Gastroenterology 90

Co-authors: William J. Sandborn William J. Tremaine William S. Harmsen Alan R. Zinsmeister Jean‐Frédéric Colombel Darrell S. Pardi Laurent Peyrin‐Biroulet Remo Panaccione
Journals: Gastroenterology (168 papers)The American Journal of Gastroenterology (137 papers)Inflammatory Bowel Diseases (118 papers)Journal of Crohn s and Colitis (87 papers)Clinical Gastroenterology and Hepatology (38 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Edward V. Loftus

733 papers receiving 36.4k citations

Hit Papers

15 papers align trajectories log scale

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease 2023 · 218 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 New England Journal of Medicine
2019 New England Journal of Medicine
2018 Radiology
2018 The American Journal of Gastroenterology
2016 Gut
2016 Clinical Gastroenterology and Hepatology
2013 Gut
2010 Gastroenterology
2009 The American Journal of Gastroenterology
2008 Gastroenterology
2006 Inflammatory Bowel Diseases
2004 Gut
2004 Gastroenterology
2003 Gastroenterology
2002 Gastroenterology
2001 Gastroenterology

Peers

Countries citing papers authored by Edward V. Loftus

Since Specialization

Citations

This map shows the geographic impact of Edward V. Loftus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward V. Loftus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward V. Loftus more than expected).

Fields of papers citing papers by Edward V. Loftus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward V. Loftus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward V. Loftus. The network helps show where Edward V. Loftus may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward V. Loftus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward V. Loftus Line = papers co-authored together Edward V. Loftus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	P0982 Efficacy of upadacitinib in patients with Crohn’s disease and an ostomy: A matched retrospective real-world cohort analysis Journal of Crohn s and Colitis ·J Cremer, Andrés Yarur, Jaehyun Bae, Edward V. Loftus, Jean–Frédéric Colombel, Parakkal Deepak	2025	0
2	Benefit–risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn’s disease Journal of Crohn s and Colitis ·Séverine Vermeire, Jean–Frédéric Colombel, Silvio Danese, Remo Panaccione, Laurent Peyrin‐Biroulet, 유명옥, María Chaparro, Javier P. Gisbert, Elena Dubcenco, M. A. Gully-Santiago, K. Lyudmil, A Birjukov, Valencia P. Remple, Namita Joshi, George Mf, Benjamin Duncan, Yibo Wang, 菊池千秋, Edward V. Loftus	2025	0
3	Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis Gastroenterology ·Ashwin N. Ananthakrishnan, M. Hassan Murad, Frank I. Scott, Manasi Agrawal, John P. Haydek, Berkeley N. Limketkai, Edward V. Loftus, Siddharth Singh	2024	18
4	Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn’s Disease Inflammatory Bowel Diseases ·Reena Khanna, Brian G. Feagan, Guangyong Zou, Larry Stitt, John WD McDonald, Brian Bressler, Remo Panaccione, Lisa M. Shackelton, 宮田佳英, Edward V. Loftus, Marco Daperno, Vipul Jairath, Geert D’Haens, William J. Sandborn	2024	2
5	Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn’s Disease and 4 Years in Ulcerative Colitis Journal of Crohn s and Colitis ·Subrata Ghosh, Brian G. Feagan, Elyssa Ott, Christopher Gasink, Yvonne Guers-Villate, Colleen Marano, Miao Ye, C. Onderka, Edward V. Loftus, William J. Sandborn, Silvio Danese, María T. Abreu, Bruce E. Sands	2024	17
6	Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies Crohn s & Colitis 360 ·William J. Sandborn, Jingjing Chen, Krisztina Kisfalvi, Edward V. Loftus, Geert D’Haens, 尚樹賦勺, Karen Lasch, Douglas C. Wolf, Mallik Alassery, Silvio Danese	2023	6
7	Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn’s Disease and Ulcerative Colitis PharmacoEconomics - Open ·Edward V. Loftus, Ashwin N. Ananthakrishnan, Wan‐Ju Lee, Yuri Sánchez González, M Gabrielle, Kori Wallace, Wen Zhou, Leighann Litcher‐Kelly, Almasaula Shofi Wiridantiansi, Tilmann Werner, Silvio Danese	2023	8
8	Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme Journal of Crohn s and Colitis ·Tim Raine, Yoh Ishiguro, David T. Rubin, Tricia Finney‐Hayward, 盛岡のぞみ, John Liu, Charles M. Phillips, L V Rodkevich, Laura E. Targownik, Edward V. Loftus	2023	4
9	DOP38 Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 Journal of Crohn s and Colitis ·Séverine Vermeire, J F Colombel, Ken Takeuchi, Xiang Gao, Remo Panaccione, Silvio Danese, Marla C. Dubinsky, Stefan Schreiber, Dapo Ilo, Tricia Finney‐Hayward, Wen Zhou, Charles M. Phillips, Xuan Yao, Qian Zhou, Edward V. Loftus	2022	10
10	Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease Crohn s & Colitis 360 ·Quazim A. Alayo, Ahmed M Khamiss, Osama Altayar, Kerri Glassner, Ernesto M. Llano, Kindra Clark‐Snustad, Anish Patel, Kenneth Patrick, Andrés Yarur, Benjamin L. Cohen, Matthew A. Ciorba, Deborah A. Thomas, Scott D. Lee, Edward V. Loftus, David Fudman, Bincy Abraham, Jean‐Frédéric Colombel, Parakkal Deepak	2022	57
11	Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials Journal of Crohn s and Colitis ·Julián Panés, Séverine Vermeire, Marla C. Dubinsky, Edward V. Loftus, Nervin Lawendy, Wenjin Wang, Leonardo Salese, Chinyu Su, Irene Modesto, Xiang Guo, Jean‐Frédéric Colombel	2021	20
12	Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience Crohn s & Colitis 360 ·Guilherme Piovezani Ramos, Badr Al‐Bawardy, Manuel B. Braga Neto, Adam C. Bledsoe, Kevin P. Quinn, H.A. North, Maria Alice V. Willrich, Rochele da Silva FERNANDES, Victor Chedid, Nayantara Coelho‐Prabhu, John B. Kisiel, Konstantinos A. Papadakis, Darrell S. Pardi, Sunanda V. Kane, William J. Tremaine, Laura E. Raffals, David H. Bruining, William A. Faubion, William S. Harmsen, Edward V. Loftus	2021	2
13	Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1 SHILAP Revista de lepidopterología ·Edward V. Loftus, Taylor Littlejohn, Colombel Jf, Iris Dotan, Samiksha Verma, Avanthi Devi, 有加二階堂	2020	0
14	Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study Gut ·Thomas G. Cotter, Moritz Binder, Edward V. Loftus, R. W. Furneaux, Reginaldo Martins da Silva de Souza, Thomas C. Smyrk, William J. Tremaine, William J. Sandborn, Darrell S. Pardi	2016	26
15	The safety of vedolizumab for ulcerative colitis and Crohn's disease Gut ·Jean‐Frédéric Colombel, Bruce E. Sands, Paul Rutgeerts, William J. Sandborn, Silvio Danese, Geert D’Haens, Remo Panaccione, Edward V. Loftus, Serap Sankoh, Irving H. Fox, Asit Parikh, Catherine Milch, Brihad Abhyankar, Brian G. Feagan Hit paper breakdown →	2016	563
16	Peripheral neuropathy incidence in inflammatory bowel disease Neurology ·Juan J. Figueroa, Edward V. Loftus, William S. Harmsen, P. James B. Dyck, Christopher J. Klein	2013	30
17	Meta‐analysis: serological markers and the risk of acute and chronic pouchitis Alimentary Pharmacology & Therapeutics ·Siddharth Singh, Piyush Kumar Sharma, Edward V. Loftus, Darrell S. Pardi	2013	41
18	Pediatric “PSC‐IBD”: A Descriptive Report of Associated Inflammatory Bowel Disease Among Pediatric Patients With PSC Journal of Pediatric Gastroenterology and Nutrition ·William A. Faubion, Edward V. Loftus, William J. Sandborn, Deborah K. Freese, Jean Perrault	2001	8
19	Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: Is it true and does it matter? Gastroenterology ·William J. Sandborn, Edward V. Loftus, David A. Ahlquist	1998	11
20	Interactions between chronic liver disease and inflammatory bowel disease Inflammatory Bowel Diseases ·Edward V. Loftus, William J. Sandborn, Keith D. Lindor, Nicholas F. LaRusso	1997	58

About Edward V. Loftus

Edward V. Loftus is a scholar working on Genetics, Gastroenterology, Epidemiology, Hepatology and Surgery, having authored 773 papers that have together received 37.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (602 papers), Microscopic Colitis (437 papers), Eosinophilic Esophagitis (94 papers), Liver Diseases and Immunity (59 papers), Diverticular Disease and Complications (54 papers), Autoimmune and Inflammatory Disorders (50 papers), Helicobacter pylori-related gastroenterology studies (46 papers) and Immunodeficiency and Autoimmune Disorders (41 papers). The work is most often cited by research in Genetics (26.3k citations), Epidemiology (21.5k citations), Gastroenterology (3.4k citations), Hepatology (2.6k citations) and Surgery (13.7k citations). Edward V. Loftus has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William J. Sandborn, William J. Tremaine, William S. Harmsen, Alan R. Zinsmeister, Jean‐Frédéric Colombel, Darrell S. Pardi, Laurent Peyrin‐Biroulet, Remo Panaccione, William A. Faubion and David H. Bruining. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Journal of Crohn s and Colitis and Clinical Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact